https://ift.tt/eA8V8J
https://www.ndtv.com
The decision regarding enhancing interval between two doses of Covishield was based on scientific evidence and taken in a transparent manner, NTAGI Chair N K Arora said on Tuesday.
from NDTV News - Topstories https://ift.tt/3xnUqLP
via IFTTT
Post a Comment